Stallergenes Greer and Aptar Pharma to develop immunotherapy treatment device
The development of the device is being carried out by Aptar Pharma’s Digital Health group - News - PharmaTimes
Stay updated with breaking news from Aptar Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The development of the device is being carried out by Aptar Pharma’s Digital Health group - News - PharmaTimes
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into an exclusive partnership with Aptar Pharma, a global leader
The Smart Inhalers Market To Step Into The Curve Of Exponential Growth (Reaching US$ 130 Million) Between 2026
/PRNewswire/ -- The "Global Drug Delivery Devices Market (2021-2026) by device type, route of administration, application, end-user, vehicle outlook,...
/PRNewswire/ -- The "Global Drug Delivery Devices Market (2021-2027) by device type, route of administration, application, end-user, vehicle outlook, and...